Compare Neurocrine Biosciences Inc (NBIX) vs Global X Robo Global Robotics & Automation ETF (ROBO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Neurocrine Biosciences Inc vs Global X Robo Global Robotics & Automation ETF — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Global X Robo Global Robotics & Automation ETF trades at $79.51. The key difference: Neurocrine Biosciences Inc is trading nearer its 52-week high, Global X Robo Global Robotics & Automation ETF nearer its low. Which is the better fit depends on your goals.
| NBIX | ROBO | |
|---|---|---|
Market Cap | $17.40B | — |
Sector | Health | Sector/Thematic |
52-Week High | $180.55 | $90.34 |
52-Week Low | $123.10 | $61.34 |
Enterprise Value | $16.49B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
ROBO Global Robotics and Automation Index ETF trades at $77.31, down 0.74% with a bearish technical signal from moving averages. The ETF provides diversified exposure to robotics and AI themes with 79 holdings across machinery and electronic equipment sectors. Recent index rebalancing has shifted weight toward AI infrastructure and physical automation themes, reflecting evolving technology trends.
The ETF offers growth exposure to the expanding physical AI ecosystem but faces cyclical risks from industrial markets. While thematic positioning remains relevant, valuation concerns exist with a 24.9x P/E ratio. Key catalysts include AI infrastructure development and reshoring trends, though competition and market volatility present ongoing challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Neurocrine Biosciences Inc
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →About Global X Robo Global Robotics & Automation ETF
ROBO is a thematic ETF that tracks the global robotics and automation industry. It provides diversified exposure to companies leading in industrial robotics, 3D printing, and surgical systems, with holdings like Intuitive Surgical and Zebra Technologies.
Read more on ROBO →
